Summit Trail Advisors LLC Lowers Stock Position in The Clorox Company (NYSE:CLX)

Summit Trail Advisors LLC cut its holdings in The Clorox Company (NYSE:CLX) by 1.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,267 shares of the company’s stock after selling 132 shares during the quarter. Summit Trail Advisors LLC’s holdings in Clorox were worth $1,265,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Core Wealth Advisors Inc. purchased a new stake in Clorox during the 4th quarter valued at about $29,000. Innealta Capital LLC purchased a new position in Clorox in the 2nd quarter worth about $30,000. Trifecta Capital Advisors LLC lifted its stake in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares during the period. GoalVest Advisory LLC purchased a new position in shares of Clorox during the first quarter valued at approximately $31,000. Finally, First Foundation Advisors purchased a new position in shares of Clorox during the first quarter valued at approximately $31,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Up 0.8 %

NYSE CLX opened at $163.33 on Friday. The stock has a 50 day moving average price of $149.14 and a 200-day moving average price of $143.73. The Clorox Company has a one year low of $114.68 and a one year high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The company has a market capitalization of $20.28 billion, a P/E ratio of 84.63, a P/E/G ratio of 3.29 and a beta of 0.40.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. As a group, equities analysts predict that The Clorox Company will post 6.63 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.99%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.51% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the topic of several research analyst reports. Wells Fargo & Company lowered their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target for the company. Barclays raised their price objective on shares of Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a report on Monday, August 5th. DA Davidson reaffirmed a “neutral” rating and set a $153.00 target price on shares of Clorox in a report on Friday, September 6th. Finally, BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Six research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $143.50.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.